Flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension Irlanda - inglese - HPRA (Health Products Regulatory Authority)

flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension

mundipharma pharmaceuticals limited - fluticasone propionate; formoterol fumarate dihydrate - pressurised inhalation, suspension - 125 µg/5 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone

FLIXOTIDE INHALER CFC FREE 125 MCG Israele - inglese - Ministry of Health

flixotide inhaler cfc free 125 mcg

glaxo smith kline (israel) ltd - fluticasone propionate - suspension for inhalation - fluticasone propionate 125 mcg/dose - fluticasone - fluticasone - prophylactic management of all grades of asthma.

Flixotide Evohaler 125 micrograms per metered dose pressurised inhalation, suspension Irlanda - inglese - HPRA (Health Products Regulatory Authority)

flixotide evohaler 125 micrograms per metered dose pressurised inhalation, suspension

pco manufacturing ltd. - fluticasone propionate - pressurised inhalation, suspension - 125 microgram(s) - glucocorticoids; fluticasone

Flutiform K-haler 125 microgram/5 microgram per actuation pressurised inhalation, suspension Irlanda - inglese - HPRA (Health Products Regulatory Authority)

flutiform k-haler 125 microgram/5 microgram per actuation pressurised inhalation, suspension

mundipharma pharmaceuticals limited - fluticasone propionate; formoterol fumarate dihydrate - pressurised inhalation, suspension - 125 µg/5 µg/actuation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone

Flixotide Evohaler 125 micrograms per metered dose Pressurised Inhalation, Suspension Irlanda - inglese - HPRA (Health Products Regulatory Authority)

flixotide evohaler 125 micrograms per metered dose pressurised inhalation, suspension

imed healthcare ltd. - fluticasone propionate - pressurised inhalation, suspension - 125 microgram(s) - glucocorticoids; fluticasone

Flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension Irlanda - inglese - HPRA (Health Products Regulatory Authority)

flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension

imed healthcare ltd. - fluticasone propionate; formoterol fumarate - pressurised inhalation, suspension - 125/5 µg/µg - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone

APO-FLUTICASONE HFA METERED-DOSE AEROSOL Canada - inglese - Health Canada

apo-fluticasone hfa metered-dose aerosol

apotex inc - fluticasone propionate - metered-dose aerosol - 250mcg - fluticasone propionate 250mcg - adrenals

APO-FLUTICASONE HFA AEROSOL, METERED DOSE Canada - inglese - Health Canada

apo-fluticasone hfa aerosol, metered dose

apotex inc - fluticasone propionate - aerosol, metered dose - 50mcg - fluticasone propionate 50mcg

MYLAN-AZELASTINE/FLUTICASONE SPRAY, METERED DOSE Canada - inglese - Health Canada

mylan-azelastine/fluticasone spray, metered dose

mylan pharmaceuticals ulc - fluticasone propionate; azelastine hydrochloride - spray, metered dose - 50mcg; 137mcg - fluticasone propionate 50mcg; azelastine hydrochloride 137mcg

Flixotide Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

flixotide

glaxosmithkline nz limited - fluticasone propionate 125ug;   - aerosol inhaler, metered dose - 125 mcg/dose - active: fluticasone propionate 125ug   excipient: norflurane - fluticasone propionate has a marked anti-inflammatory effect in the lungs. it reduces symptoms and exacerbations of asthma in patients previously treated with bronchodilator alone or with other prophylactic therapy. severe asthma requires regular medical assessment as death may occur. patients with severe asthma have constant symptoms and frequent exacerbations, with limited physical capacity, and pef values below 60% predicted at baseline with greater than 30% variability, usually not returning entirely to normal after a bronchodilator. these patients will require high dose inhaled (see dosage instructions) or oral corticosteroid therapy. sudden worsening of symptoms may require increased corticosteroid dosage which should be administered under urgent medical supervision.